Second Joint Working Conference: National Cancer Institute Chemotherapy Program. Working session report: dose formulation.
D000062:Accidents, Occupational; D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000592:standards; D004304:Dosage Forms; D004345:Drug Industry; D004355:Drug Stability; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D004304:Dosage Forms